Should We Encourage Over-The-Counter Statins?: A Population Perspective for Coronary Heart Disease Prevention

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.7, Iss.4, 2007-01, pp. : 299-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Statins for the Primary and Secondary Prevention of Coronary Heart Disease in Women

Current Pharmaceutical Design, Vol. 15, Iss. 10, 2009-04 ,pp. : 1054-1062

Bentham Science Publishers

Access to resources Recommend Favorite

The future of coronary heart disease prevention

By Wald David S

Clinical Medicine, Vol. 7, Iss. 4, 2007-08 ,pp. : 392-396

Royal College Of Physicians

Access to resources Recommend Favorite

Pharmacokinetic Comparison of the Potential Over-the-Counter Statins Simvastatin, Lovastatin, Fluvastatin and Pravastatin

By Neuvonen Pertti J. Backman Janne T. Niemi Mikko

Clinical Pharmacokinetics, Vol. 47, Iss. 7, 2008-01 ,pp. : 463-474

Adis International

Access to resources Recommend Favorite

Zanamivir should be available over-the-counter in the UK, says NICE chairman

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 260, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Statins and telomere length: risk assessment and management for coronary heart disease

By Tiwari Atul

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 7, 2007-07 ,pp. : 979-982

Informa Healthcare

Access to resources Recommend Favorite